Clinical Trials Browser

Terminated × Carcinoma, Renal Cell × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT00090870 2018-07-12

PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer

Phase 2 Terminated

10 enrolled 4 charts

Carcinoma, Renal Cell, Kidney Neoplasms